Protocol Design White Papers & Case Studies

  1. Your Oncology CRO Dilemma Solved 7/22/2024

    Palleos Oncology™ is a comprehensive solution designed to support pharmaceutical companies throughout the entire lifecycle of oncology treatment development.

  2. Help Bring Your Breakthrough Cancer Treatments To Market Faster 7/18/2024

    Let us expedite the journey of your treatment from the research phase to the patient, ensuring that life-saving therapies reach those in need as swiftly as possible.

  3. Why Leading Cancer Research Centers Trust OpenClinica For Oncology Trials 7/16/2024

    See eight key reasons why leading cancer research centers rely on OpenClinica to navigate the intricacies of oncology trials and advance the field of cancer research.

  4. RTSM And Clinical Drug Dispensation 7/16/2024

    A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.

  5. Medable Platform Delivers >90% eCOA Adherence And Scalability 7/8/2024

    Discover how eCOA use drove >90% adherence across an extensive weight management master protocol clinical trial with multiple sub-studies across 70+ research sites.

  6. Radiopharmaceutical Therapy: Global Clinical Trial Insights 2024 7/3/2024

    By downloading this report, readers will uncover the transformative potential of radiopharmaceuticals in cancer therapy and stay ahead in the evolving cancer treatment landscape.

  7. Non-Small Cell Lung Cancer — Global Clinical Trial Landscape (2024) 7/3/2024

    Explore cutting-edge Non-Small Cell Lung Cancer (NSCLC) research with Novotech CRO's in-depth disease analysis, providing insights into innovative therapies, clinical trials, and future directions shaping NSCLC care globally.

  8. Liver Cancer — Global Clinical Trial Landscape (2024) 7/3/2024

    Explore the latest advancements and clinical trial landscape in liver cancer research with Novotech CRO's comprehensive disease report.

  9. Decisions In Cell And Gene Therapy Development 7/2/2024

    Explore critical decisions across clinical trial design, patient recruitment, site selection, logistics, manufacturing, and long-term follow-up, aiming to guide stakeholders through CAGT development.

  10. Strengthening Pathways For Cell And Gene Therapies 7/2/2024

    This report aims to spur informed discussions on the future trajectory of cell and gene therapies and their pivotal role in shaping the future of healthcare.